BACKGROUND: ADAM 33 is the first gene identified as a candidate for asthma by positional cloning techniques, with association studies reaching impressive statistical significance. It has a postulated role in myogenesis, airway modelling, and signalling via protein shedding. Concerns over the methodology of the initial study have led to several attempts at replication, with inconsistent results. METHOD: To clarify the role of ADAM33 in determining the risk of asthma in the general population, new transmission disequilibrium and case-control studies were undertaken followed by a meta-analysis of all existing data. RESULTS: Studies in Icelandic and UK populations revealed no association when taken in isolation. The meta-analysis, however, showed that the F+1 and ST+7 variants were significantly associated with asthma in both types of study. CONCLUSIONS: The additional risk imparted by this variation would account for 50,000 excess asthma cases in the UK alone. This study also demonstrates the size of study required to investigate such hypotheses adequately.
BACKGROUND:ADAM 33 is the first gene identified as a candidate for asthma by positional cloning techniques, with association studies reaching impressive statistical significance. It has a postulated role in myogenesis, airway modelling, and signalling via protein shedding. Concerns over the methodology of the initial study have led to several attempts at replication, with inconsistent results. METHOD: To clarify the role of ADAM33 in determining the risk of asthma in the general population, new transmission disequilibrium and case-control studies were undertaken followed by a meta-analysis of all existing data. RESULTS: Studies in Icelandic and UK populations revealed no association when taken in isolation. The meta-analysis, however, showed that the F+1 and ST+7 variants were significantly associated with asthma in both types of study. CONCLUSIONS: The additional risk imparted by this variation would account for 50,000 excess asthma cases in the UK alone. This study also demonstrates the size of study required to investigate such hypotheses adequately.
Authors: Denise L Lind; Shweta Choudhry; Ngim Ung; Elad Ziv; Pedro C Avila; Keyan Salari; Connie Ha; Elizabeth G Lovins; Natasha E Coyle; Sylvette Nazario; Jesus Casal; Alfonso Torres; Jose R Rodriguez-Santana; Henry Matallana; Craig M Lilly; Jorge Salas; Moises Selman; Homer A Boushey; Scott T Weiss; Rocio Chapela; Jean G Ford; William Rodriguez-Cintron; Edwin K Silverman; Dean Sheppard; Pui-Yan Kwok; Esteban González Burchard Journal: Am J Respir Crit Care Med Date: 2003-09-04 Impact factor: 21.405
Authors: H Jongepier; H M Boezen; A Dijkstra; T D Howard; J M Vonk; G H Koppelman; S L Zheng; D A Meyers; E R Bleecker; D S Postma Journal: Clin Exp Allergy Date: 2004-05 Impact factor: 5.018
Authors: J H Lee; H-S Park; S W Park; A S Jang; S T Uh; T Rhim; C-S Park; S-J Hong; S T Holgate; J W Holloway; H D Shin Journal: Clin Exp Allergy Date: 2004-06 Impact factor: 5.018
Authors: Shelby P Umland; Charles G Garlisi; Himanshu Shah; Yuntao Wan; Jun Zou; Kristine E Devito; Whei-Mei Huang; Eric L Gustafson; Robert Ralston Journal: Am J Respir Cell Mol Biol Date: 2003-05-30 Impact factor: 6.914
Authors: Robert M Powell; James Wicks; John W Holloway; Stephen T Holgate; Donna E Davies Journal: Am J Respir Cell Mol Biol Date: 2004-01-23 Impact factor: 6.914
Authors: Denise Daley; Mathieu Lemire; Loubna Akhabir; Moira Chan-Yeung; Jian Qing He; Treena McDonald; Andrew Sandford; Dorota Stefanowicz; Ben Tripp; David Zamar; Yohan Bosse; Vincent Ferretti; Alexandre Montpetit; Marie-Catherine Tessier; Allan Becker; Anita L Kozyrskyj; John Beilby; Pamela A McCaskie; Bill Musk; Nicole Warrington; Alan James; Catherine Laprise; Lyle J Palmer; Peter D Paré; Thomas J Hudson Journal: Hum Genet Date: 2009-02-27 Impact factor: 4.132
Authors: Emma Gutiérrez de Mesa; Ignacio Hidalgo; Panayotis Christidis; Juan Carlos Ciscar; Eva Vegas; Dolores Ibarreta Journal: Mol Diagn Ther Date: 2007 Impact factor: 4.074